Pharma & Competition Law - Latest Practice Update

Introduction

Competition law and enforcement is a perennial concern for clients in the pharma sector since this is a rapidly changing area, due to increased enforcement and frequent appeals and litigation in pharma cases.

This virtual classroom session will bring you up to date on the recent cases and judgments relevant to the pharma sector in the EU and UK.

The content is suitable for all UK regions and Europe and is suitable for anyone advising on competition law in the pharmaceutical sectors or who has clients in the life sciences or pharmaceutical industry and is advising on compliance issues including competition law.

What You Will Learn

This live and interactive course will cover the following:

• Recent trends in the pharmaceutical sector and competition law and updates on enforcement and progress of investigations in the sector
• Abuse of dominance cases in pharma in the EU and UK
• Investigations into excessive pricing, cases in the EU Aspen and the UK Pfizer/Flynn
• Rebates in the pharma sector, recent developments
• Disparagement cases - product denigration and the Vifor Pharma case
• Patent settlement cases (pay-for-delay cases) and appeals -the Servier case and its implications, the European Commission statement of objections in the Teva Copaxone case
• Mergers in the pharma sector
• Illumina / Grail case: procedural aspects, merits of the case, and the on-going gun jumping investigation
• Theories of harm in pharma mergers and innovation and ‘killer acquisitions’
• Guidance on referral mechanism in Article 22 EUMR in relation to pharmaceutical and biotech sectors

Recording of live sessions: Soon after the Learn Live session has taken place you will be able to go back and access the recording - should you wish to revisit the material discussed.